HER2 overexpression promotes the activation of the HSF1-Hsp90 axis and the stabilization of Hsp90 client proteins, such as MIF, AKT, and mTOR, leading to increased tumor growth [99] (Figure 2). This evidence concerns the gene ERBB2 and neoplasm.